Covered recipient · General Payments record
FREDERICK J A FONT
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$3,954.41
- Reported across 184 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $142.71 | 7 |
| GlaxoSmithKline, LLC. | $60.37 | 3 |
| Mallinckrodt Hospital Products Inc. | $54.60 | 2 |
| Alvogen Inc | $27.19 | 1 |
| ANI Pharmaceuticals, Inc. | $26.38 | 1 |
| PFIZER INC. | $20.85 | 1 |
| Aurinia Pharma U.S., Inc. | $18.97 | 1 |
| Organon LLC | $12.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.86 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741029 | CMS |
| ABBVIE INC. | $24.31 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741031 | CMS |
| ABBVIE INC. | $7.74 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741033 | CMS |
| ABBVIE INC. | $26.67 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741035 | CMS |
| ABBVIE INC. | $28.20 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741037 | CMS |
| ABBVIE INC. | $10.14 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741039 | CMS |
| ABBVIE INC. | $34.79 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741041 | CMS |
| Alvogen Inc | $27.19 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137624247 | CMS |
| ANI Pharmaceuticals, Inc. | $26.38 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091164216 | CMS |
| Aurinia Pharma U.S., Inc. | $18.97 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150680209 | CMS |
| GlaxoSmithKline, LLC. | $17.73 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116638642 | CMS |
| GlaxoSmithKline, LLC. | $20.79 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116392974 | CMS |
| GlaxoSmithKline, LLC. | $21.85 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116627874 | CMS |
| Mallinckrodt Hospital Products Inc. | $28.10 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145072105 | CMS |
| Mallinckrodt Hospital Products Inc. | $26.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145072110 | CMS |
| Organon Llc | $12.19 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136279842 | CMS |
| PFIZER INC. | $20.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131882618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.